H1 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: INNOVENT BIO(01801) the Revenue is 9.946 B (+52.73%), Miss estimate;the EBIT is 1.272 B (+56.66%), Beat estimate;the EPS is 0.808 (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
9.95B52.73%
11.35B74.32%
-1.41B21.59%
EBITExceed expectations
1.27B56.66%
1.26B55.02%
+0.01B1.64%
EPSExceed expectations
0.8079--
0.5424--
+0.2655--%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf